Meglumine diatrizoate is a salt or mixture formed from diatrizoic acid and meglumine, used as a diagnostic contrast medium. It is supplied as a pharmaceutical raw material for manufacturing contrast agents employed in medical imaging procedures.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Meglumine diatrizoate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Methylglucamine hydrochloride
pharmaceutical intermediate
Meglumine
pharmaceutical raw material
Tafamidis meglumine
pharmaceutical raw material
Dioxybenzone
pharmaceutical raw material
Boldenone undecylenate
pharmaceutical raw material
3'-Hydroxypropiophenone
pharmaceutical raw material
Upadacitinib
pharmaceutical raw material
The international HS code for Meglumine diatrizoate (CAS 131-49-7) is 2924.29.
2924.29
2924 29 70
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
3,5-diacetamido-2,4,6-triiodobenzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
MIKKOBKEXMRYFQ-WZTVWXICSA-N
CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
Sourcing Meglumine diatrizoate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.